Donoghue Forlines’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,230
Closed -$1.41M 197
2024
Q3
$1.41M Buy
4,230
+313
+8% +$119K 0.4% 75
2024
Q2
$1.61M Sell
3,917
-61
-2% -$24.2K 0.46% 44
2024
Q1
$1.61M Sell
3,978
-948
-19% -$333K 0.46% 64
2023
Q4
$1.51M Buy
4,926
+15
+0.3% +$4.05K 0.47% 47
2023
Q3
$1.19M Buy
+4,911
New +$1.26M 0.42% 78

Other funds holding MEDP

Donoghue Forlines's MEDP Position: Q4 2024 in Review

Donoghue Forlines sold out of Medpace (MEDP) in Q4 2024, closing a stake of 4,230 shares — an estimated $1.41M sold.

Donoghue Forlines first reported a position in MEDP in Q3 2023 and held it in 5 quarters. The position peaked at $1.61M in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Donoghue Forlines reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Donoghue Forlines sold 4,230 Medpace shares in Q4 2024, an estimated $1.41M.
  • Donoghue Forlines first reported a position in Medpace in Q3 2023 and held it in 5 quarters.
  • Donoghue Forlines's Medpace position peaked at $1.61M in Q2 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Donoghue Forlines's 13F filing for Q4 2024, filed 17 Jan 2025.